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ABSTRACT
New effective strategies and new highly effective neuroprotective agents are being searched for the therapy of human stroke and 
cerebral ischemia. The compound SMe1EC2 is a new derivative of stobadine, with enhanced antioxidant properties compared to the 
maternal drug. Carvedilol, a non-selective beta-blocker, possesses besides its cardioprotective and vasculoprotective properties also 
an antioxidant effect. We compared the effect of carvedilol and SMe1EC2, antioxidants with a similar chemical structure, in two experi-
mental models of oxidative stress in young and adult rat brain tissue. SMe1EC2 was found to improve the resistance of hippocampal 
neurons to ischemia in vitro in young and even in 18-month-old rats and inhibited formation of protein carbonyl groups induced by 
the Fe2+/ascorbic acid pro-oxidative system in brain cortex homogenates of young rats. Carvedilol exerted a protective effect only 
in the hippocampus of 2-month-old rats and that at the concentration 10-times higher than did SMe1EC2. The inhibitory effect of 
carvedilol on protein carbonyl formation induced by the pro-oxidative system was not proved in the cortex of either young or adult 
rats. An increased baseline level of the content of protein carbonyl groups in the adult versus young rat brain cortex confirmed 
age-related changes in neuronal tissue and may be due to increased production of reactive oxygen species and low antioxidant 
defense mechanisms in the adult rat brain. The results revealed the new pyridoindole SMe1EC2 to be more effective than carvedilol 
in neuroprotection of rat brain tissue in both experimental models involving oxidative stress. 
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purity < 99%), a derivative of stobadine (STO), (both syn-
thetized in the Institute of Experimental Pharmacology 
and  Toxicology,  Slovak  Academy  of  Sciences,  Slovak 
Republic) was recently found to have a higher antioxidant 
capability than the parent compound STO with estab-
lished neuroprotective and cardioprotective properties 
(Horáková & Štolc, 1998, Štolc et al., 2006). A toxico-
logical and teratological study of SMe1EC2 showed its 
low toxicity and no embryotoxic and teratogenic effects 
on developing rats (Štolc et al., 2008, Ujházy et al., 2008). 
 Carvedilol, a non-selective beta-blocker with alpha-
blocker properties, currently used to treat hypertension, 
heart failure and coronary artery diseases, has besides 
its  cardioprotective  and  vasculoprotective  properties 
also antioxidant effects. The antioxidant properties of 
Introduction
Major interest is currently focused on the development of 
new effective strategies and new highly effective agents 
for the pharmacological therapy of human stroke and 
cerebral ischemia.
The  new  substance  2-ethoxycarbonyl-8-methoxy-
2,3,4,4a,5,9b-hexahydro-1H-pyrido-[4,3b]indolinium 
chloride with the code SMe1EC2 (m.w. 312.79 Da, chemical 
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carvedilol, and its relation to mitochondrial oxidative 
phosphorylation, calcium homeostasis and energy pro-
duction, make this drug a unique beta-blocker, reinforc-
ing its advantageous use in cardiac pathologies associated 
with  enhanced  cellular  oxidative  stress.  Carvedilol 
administered  subcutaneously  directly  after  transient 
forebrain ischemia protected a population of neurons in 
the hippocampal CA1 area in gerbils (Strosznajder et al., 
2005). Thus carvedilol raises high expectations also in the 
therapy of ischemia. 
Both  compounds  tested,  carvedilol  and  SMe1EC2, 
have a tri-cyclic basal skeleton bridged by the NH group. 
This represents the active site of the molecule responsible 
for interaction with free radicals (Figure 1). The anti-
oxidant activity of both molecules is caused by the ability 
of the NH group to scavenge radicals by abstraction of 
the hydrogen from the NH group and by subsequent 
formation of a more stable N radical. Both compounds 
have an electron-donor group on the aromatic skeleton, 
which increases the stability of the N radical and thus its 
viability. 
In two experimental models involving oxidative stress 
on rat brain tissues, we studied the effect of the new 
pyridoindole SMe1EC2, derived from the neuroprotec-
tive and cardioprotective drug STO, and of carvedilol, a 
beta adrenoreceptor antagonist with potent antioxidant 
properties. We focused on 1) comparison of the effect of 
carvedilol and SMe1EC2 on the resistance of the rat hip-
pocampus exposed to model ischemia in vitro (transient 
glucose/oxygen deprivation followed by reoxygenation), 
and on 2) comparison of their effect on protein carbonyl 
formation induced by the Fe2+/ascorbic acid pro-oxidative 
system in the rat brain cortex, both in young and adult 
rats.
Methods
Animals
Male  Wistar  rats  aged  2,  10  and  18  months  (weight 
216 ± 8 g; 450 ± 8 g and 497 ± 7 g, respectively) (n=20, n=22 
and n=15, respectively) from the breeding station Dobrá 
Voda (Slovak Republic, reg. No. SK CH 4004) were used 
in  electrophysiological  and  biochemical  experiments. 
The rats had free access to water and food pellets and 
were kept on a 12/12 h light/dark cycle. All procedures 
involving animals were performed in compliance with the 
Principles of Laboratory Animal Care issued by the Ethical 
Committee of the Institute of Experimental Pharmacology 
and Toxicology, Slovak Academy of Sciences and by the 
State Veterinary and Food Administration of the Slovak 
Republic. 
Drugs
The pyridoindole derivative SMe1EC2 was synthetized 
in  the  Institute  of  Experimental  Pharmacology  and 
Toxicology, Slovak Academy of Sciences, Slovak Republic.
Carvedilol,  (±)-1-(Carbazol-4-yloxy)-3-[[2-(o-
methoxyphenoxy)ethyl]amino]-2-propanol was obtained 
from La Roche (Mannheim, Germany). Stock solution of 
carvedilol in the concentration of 1 mmol/l was prepared 
by dissolution in wine acid and distilled water, heated up 
to 37 °C and sonicated three times for 5 min.
Oxygen/glucose deprivation and field action 
potential in rat hippocampal slices
Rat  hippocampal  slices  (400 µm)  were  prepared  by 
a  conventional  technique  described  in  detail  earlier 
(Vlkolinský & Štolc, 1999, Gáspárová et al., 2006). Bipolar 
wire electrodes were used to stimulate Schäffer collater-
als evoking trans-synaptically activity in the CA1 area. 
Field action potential (FAP) was registered in the CA1 
pyramidal cell layer by a glass microelectrode and stored 
in the computer for further analysis. Oxygen/glucose 
deprivation  was  obtained  by  replacement  of  the  gas 
mixture containing O2 with the gas mixture with N2 by 
switching the valves and by replacement of the artificial 
cerebrospinal fluid (ACSF) equilibrated with oxygen to 
oxygen-free ACSF, with glucose diminished from 10 to 
4 mmol/l. Oxygen/glucose deprivation elicited a decrease 
of FAP with its subsequent decay. Hippocampal slices 
were exposed to transient 6-min hypoxia/hypoglycemia 
followed by 20-min reoxygenation. Recovery of FAP after 
hypoxia/hypoglycemia was monitored during the 20-min 
reoxygenation, while population spike (PS) amplitude 
was measured in a later analysis. Each drug tested was 
present in the superfusing ACSF throughout the whole 
experiment: 30 min before oxygen/glucose deprivation, 
during 6-min hypoxia/hypoglycemia and during 20-min 
reoxygenation. 
Pro-oxidative system of Fe2+/ascorbic acid and 
protein carbonyl formation in rat brain cortex
Protein carbonyl formation was determined by the method 
of Levine and coworkers (1990), modified by Blackburn 
and coworkers (1999) where 2,4-dinitrophenylhydrazine 
reacts with the protein carbonyl group and protein hydra-
zon is generated, which is detected spectrophotometri-
cally with absorbance maximum at 360–370 nm. Proteins 
were detected spectrophotometrically in the same sample 
at 280 nm. Homogenate of the rat brain cortex (10%) was 
used. The pro-oxidative system was comprised of FeSO4 
(0.1 mmol/l) and ascorbic acid (0.5 mMmol/l). 
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Figure 1. Chemical formula of (1) carvedilol and (2) SMe1EC2.124
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Results
Effect of SMe1EC2 and carvedilol during model ischemia in vitro
Transient 6-min ischemia in vitro (hypoxia with hypo-
glycemia) elicited a decrease and failure of electrically 
evoked response recorded in the pyramidal neurons of the 
CA1 area in the rat hippocampus. Untreated control slices 
showed low recovery of electrically evoked responses at the 
end of 20-min reoxygenation. SMe1EC2 (1 and 3 µmol/l) 
significantly  improved  recovery  of  the  PS  magnitude 
at the end of reoxygenation in the hippocampus of the 
young 2-month-old rats and established a neuroprotective 
effect even in the18-month-old rats (1 µmol/l) (Figure 2). 
Carvedilol, in the concentration of 10 µmol/l, significantly 
improved the resistance of hippocampal CA1 neurons to 
transient ischemia in vitro, yet only in young rats, while 
in 10-month-old rats it had no protective effect at any 
concentration tested (3 and 10 µmol/l) (Figure 3). 
Effect of SMe1EC2 and carvedilol in Fe2+/ascorbic acid system 
The  baseline  level  of  protein  carbonyl  groups  in  the 
cortex  of  control  rats  was  significantly  higher  in  the 
adult  10-month-old  rats  (2.12 ± 0.14 nmol/mg  prot., 
n=20)  as  compared  to  the  young  2-month-old  rats 
(1.72 ± 0.12 nmol/mg  prot.,  n=22;  p<0.05).  The  Fe2+/
ascorbic acid system induced marked oxidative modifica-
tion of proteins in both the young and adult rat cortex 
homogenates,  resulting  in  an  increase  of  the  content 
of protein carbonyl groups (p<0.001). The increase of 
protein carbonyl formation was of similar intensity in 
the young rat cortex as in the adult one (187.76 ± 6.20%; 
n=14 and 178.33 ± 8.24%; n=14, respectively). The com-
pound SMe1EC2 protected brain cortex tissue against 
the oxidative damage induced by the Fe2+/ascorbic acid 
pro-oxidative system in 2-month-old rats even in a very 
low concentration (0.1 µmol/l) and showed the best effect 
in the concentration of 1 µmol/l (Figure 4). Carvedilol did 
not significantly suppress the Fe2+/ascorbic acid system 
induced carbonyl formation in the cortex of either young 
or adult rats (Figure 5).
Discussion
To date many natural and synthetic compounds have 
been  established  possessing  antioxidant  properties. 
Antioxidants  and  radical  scavengers  may  protect  the 
nervous system against toxic effects of increased levels of 
reactive oxygen species and free oxygen radicals and thus 
attract many researchers to study their effect concerning 
brain protection. 
Carvedilol is a multiple-action antihypertensive agent 
with a potential for cardiovascular protection beyond the 
normalization of high blood pressure. It has alpha1- and 
beta-adrenergic receptor blocking action, calcium chan-
nel blocking action, suppressive effect on cardiac necrosis 
and neuroprotective activities in animal models of brain 
ischemia and infarction (Ruffolo et al., 1990, Rabasseda 
1998,  Strosznajder  et  al.,  2005).  Carvedilol  exerts  an 
additional  neuroprotective  activity  as  a  Na+  channel 
modulator and glutamate release inhibitor (Lysko et al., 
1994). Recently, carvedilol was found to inhibit mitochon-
drial  permeability  transition,  mitochondrial  swelling, 
oxidation of thiol groups, and to protect mitochondria 
against oxidative damage induced by the xanthine oxi-
dase/hypoxanthine pro-oxidant system (Oliviera et al., 
2004, Oliviera et al. 2005, Carreira et al., 2006). Chronic 
administration of carvedilol resulted in an improvement 
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Figure 2. Effect of SMe1EC2 on resistance of the CA1 neurons 
in hippocampus exposed to transient ischemia in vitro: 6-min 
hypoxia with hypoglycemia followed by 20-min reoxygenation. 
Ten to 12 slices from 6–8 rats were used in each experimental 
group.  Cessation  of  field  action  potential  and  PS  amplitude 
recovery were monitored. Significant difference in the PS ampli-
tude recovery between untreated and treated slices at the end of 
20-min reoxygenation was calculated by Student´ t-test,*p<0.05, 
**p<0.01.
Figure 3. Effect of carvedilol on resistance of CA1 neurons in hip-
pocampus exposed to transient ischemia in vitro: 6-min hypoxia 
with hypoglycemia followed by 20-min reoxygenation. Nine to 
11 slices from 6–8 rats were used in each experimental group. 
Cessation of field action potential and PS amplitude recovery 
were monitored. Significant difference in the PS amplitude recov-
ery between untreated and treated slices at the end of 20-min 
reoxygenation was calculated by Student´t-test, ***p<0.001.125
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of memory retention (evaluated in the Morris water maze 
task paradigms) and in attenuation of oxidative damage 
in the streptozotocin induced model of dementia in rats 
(Prakash & Kumar, 2009). Carvedilol may have a potential 
in the treatment of neurodegenerative diseases. 
The idea of comparing the effect of these two com-
pounds tested was based on their similar chemical struc-
ture and their antioxidant properties, proved in several 
different approaches. At concentrations above 1 µmol/l, 
carvedilol was found to be a calcium channel antagonist 
(Ruffolo et al., 1990). We tested it in the concentrations 
of 1, 3 and 10 µmol/l. In our experiments, the reported 
antioxidant and neuroprotective action of carvedilol was 
proved only in the hippocampal slices of young 2-month-
old rats exposed to transient hypoxia with hypoglycemia 
followed by reoxygenation. 
The compound SMe1EC2, with an antioxidant and 
neuroprotective effect established previously (Štolc et 
al., 2006; Štolc et al., 2008; Gáspárová et al., 2009; 2010), 
improved the resistance of hippocampal neurons exposed 
to  transient  ischemia  in  vitro  in  young  and  even  in 
18-month-old rats and significantly reduced the formation 
of protein carbonyl groups induced by the pro-oxidative 
system in young rat cortex homogenates. However, no 
inhibitory effect of SMe1EC2 on protein carbonyl forma-
tion was found in adult 10-month-old rats. This finding 
might be supported by results where the protective effect 
of some antioxidants, e.g. vitamin E (Sumien et al., 2004; 
Sung et al., 2004), melatonin (von Gall & Weaver, 2008), 
garlic extract (Brunetti at al., 2009), and beta-blockers 
(Gleibus and Lippa, 2007) was not proved either in adult 
and aged experimental animals or in elderly people. The 
increased native baseline level of the content of protein 
carbonyls in adult rats and a consequent further increase 
of carbonyls due to exposure to a pro-oxidative system, 
may  be  the  reason  for  the  failed  protective  effect  of 
each antioxidant tested in adult 10-month-old rats. The 
increased baseline level of the content of protein car-
bonyl groups in the brain cortex of 10-month-old versus 
2-month-old rats found in our experiments confirmed 
age-related changes in neuronal tissue. Our results are in 
good agreement with findings, for example of Balu and 
co-workers (2005), reporting age-associated increase in 
protein oxidation and reactive oxygen species production 
in the cerebral cortex and hippocampus of aged rats. The 
determined higher level of oxidatively modified proteins 
in native rat cortex homogenates of 10-month-old rats 
compared to young ones could be due to a lower baseline 
level of antioxidants, which was reported in the neuronal 
antioxidant system of adult and aged animals compared 
to young ones (Desole et al., 1993; Squier, 2001). The 
assumption has been voiced that oxidative stress is an 
early event of chronic brain diseases and antioxidant 
therapy may be beneficial only if given at this stage of the 
disease process (Sung et al., 2004). 
Fe (II) is a potential pro-oxidant and can induce cellular 
oxidative stress. Ascorbic acid is a powerful physiological 
antioxidant and, in the presence of free Fe (II), it can exhibit 
pro-oxidant effects in vitro. We found that exposure of 
brain cortex homogenates to this pro-oxidative system 
induced an increase in protein carbonyl formation of a 
range comparable in young and adult rats. Thus in the 
pro-oxidative system tested, no age-dependent difference 
was found as to the vulnerability of brain tissue to oxida-
tive stress. To date the relation between oxidant status 
and antioxidant defense mechanisms in aged animals of 
different species, organs or sexes has been investigated 
extensively, yet the results found have frequently been 
contradictory. Further studies are needed to elucidate 
these  mechanisms  and  to  determine  the  main  signal 
pathways responsible for changes associated with aging. 
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Figure  4.  Effect  of  SMe1EC2  on  Fe2+/ascorbic  acid  induced 
protein  carbonyl  formation  in  brain  cortex.  Rat  brain  cortex 
homogenates (n=5–6 samples in each group) from 5–6 rats were 
used. The content of protein carbonyl groups was determined 
spectrophotometrically. The content of carbonyls in the pres-
ence of the pro-oxidative system without the drug tested was 
considered  100%  (Ox+0).  Inhibitory  effect  of  the  antioxidant 
tested was monitored (Ox+0.1; Ox+1; Ox+3 µmol/l of SMe1EC2). 
Significant difference in protein carbonyl content between the 
untreated  oxidation  modified  brain  cortex  homogenates  and 
the treated oxidation modified homogenates was calculated by 
Student´ t-test, *p<0.05.
Figure  5.  Effect  of  carvedilol  on  Fe2+/ascorbic  acid  induced 
protein  carbonyl  formation  in  brain  cortex.  Rat  brain  cortex 
homogenates (n=5–6 samples in each group) from 5–6 rats were 
used. The content of protein carbonyl groups was determined 
spectrophotometrically. The content of carbonyls in the pres-
ence of the pro-oxidative system without the drug tested was 
considered 100% (Ox+0). Effect of the drug tested on protein 
carbonyl content was monitored (Ox+1; Ox+3; Ox+10 µmol/l of 
carvedilol).126
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Conclusion
The compound SMe1EC2 showed a significant neuropro-
tective effect in both experimental models involving oxi-
dative stress and it was effective in lower concentrations 
than carvedilol. On the basis of previous results obtained 
with SMe1EC2, along with the findings reported here, we 
suggest that the new pyridoindole derivative SMe1EC2 is 
a new prospective and promising compound which might 
find a beneficial use in the treatment of neuronal impair-
ment, such as stroke and brain ischemia. 
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